ArticleBiology2023

Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development.

Gian Paolo Caviglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.